April 22, 2021 – NationX News

Day: April 22, 2021

Zoom launches $100M venture fund

Zoom on Tuesday announced the launch of Zoom Apps Fund, a new $100 million venture

Bharat Biotech says Covaxin shows 78pc efficacy against mild to severe COVID-19

Bharat Biotech says Covaxin shows 78pc efficacy against mild to severe COVID-19

Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown the efficacy of 78

IIT Kharagpur launches COVIRAP diagnostic technology

IIT Kharagpur launches COVIRAP diagnostic technology

IIT Kharagpur has successfully commercialised its flagship healthcare product COVIRAP, the novel diagnostic technology to

Complying with the new rule of providing 50 percent doses to state government and open market, Covishield vaccine will now be available at Rs 400 for state governments and Rs 600 for private hospitals. “Owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity. We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems. Post four to five months, the vaccines will be made available in retail and free trade,” SII said in a statement. According to government data, Covishield comprises over 90 percent of the 12.76 crore COVID-19 vaccines administered across the country Apart from this, Covaxin maker Bharat Biotech also said it will produce 30 million doses of its COVID-19 vaccine. The company stated that it has ramped up its production capacity of Covaxin to 700 million doses per annum. "Last month, we produced 15 million doses. This month, we are reaching 20 million doses; next month, we will be making around 30 million doses followed by 70 to 75 million doses. We are ramping up the production and by July-August, we will be able to reach 700 to 800 million doses production capacity per annum," said Krishna Ella, Chairman and MD at Bharat Biotech. On Wednesday, the company revealed that Covaxin has shown the efficacy of 78 percent against mild, moderate, and severe cases of COVID-19 as per Phase III interim analysis results. It also added that results from the final analysis will be available in June. New vaccines in India In order to meet the increasing demand for vaccines, India is also looking at introducing new vaccines to accelerate the fight against COVID-19. Earlier this month, Russian COVID-19 vaccine Sputnik V got permission for restricted emergency use with certain conditions from the Drugs Controller General of India (DCGI) With this approval, Sputnik V has become the third approved vaccine in India against coronavirus. Hyderabad-based pharmaceutical company, Dr. Reddy's Laboratories, which was conducting the Indian trials for Sputnik V will be importing the vaccine for emergency use in India. According to the PTI report, the Sputnik V vaccine is expected to arrive this month or latest by next month. Apart from this, Moderna, and Johnson and Johnson have also been urged to seek emergency use approval in India. In order to meet the vaccine demand, the government is also reportedly considering waiving off 10 percent customs duty levied on imported vaccines to lower the costs of overseas vaccines While vaccine makers and the government is doing their bit to ramp up vaccination efforts to eliminate coronavirus, we can only defeat the pandemic when we follow the advised protocols and take appropriate precautions. Vaccination is a preventive measure and not a cure. With the second wave of infections hitting the country, it is the need of the hour to take measures and cut the curve to eliminate the disease.

Vaccine manufacturers to ramp up production of COVID-19 vaccines ahead of Phase III drive from May 1

India’s COVID-19 situation is worsening every day. According to reports, the country has about 15.6

Zomato rolls out priority delivery feature for COVID-related food orders

Zomato rolls out priority delivery feature for COVID-related food orders

Food delivery and restaurant aggregator Zomato has rolled out a ‘priority delivery’ option for its

Conversational AI platform ORAI raises Rs 3.6 Cr from Inflection Point Ventures

Conversational AI platform ORAI raises Rs 3.6 Cr from Inflection Point Ventures

Enterprise conversational AI platform ORAI has raised Rs 3.6 crore in a Pre-Series A round

These childhood friends started MyEasyStore during lockdown to enable SMB owners set up online shop

The COVID-19 imposed lockdown shut down many small businesses, including the street food vendors, home

This IIT Guwahati alumnus has built a secure email platform to protect user privacy

This IIT Guwahati alumnus has built a secure email platform to protect user privacy

Sunit Kumar Nandi, Founder, Techno Digital Media, always found it challenging to get a safe

This SaaS startup is reducing costs for fleet operators

This SaaS startup is reducing costs for fleet operators

Digitisation of transportation, where one can track the source routes on a real-time basis, is